EGF polyclonal (C-term), anti-human

Background:
This gene encodes a member of the epidermal growth factor superfamily. The encoded protein is synthesized as a large precursor molecule that is proteolytically cleaved to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding the high affinity cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternate splicing results in multiple transcript variants.

Other Names:
Pro-epidermal growth factor, EGF, Epidermal growth factor, Urogastrone, EGF

Target/Specificity:
This EGF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 940-967 amino acids from the C-terminal region of human EGF.

Antigen Region:
940-967

Antigen Type: Synthetic Peptide

Gene Name: EGF
Gene ID: 1950
Primary Accession: P01133
NCBI Accession: NP_001171601.1;NP_001171602.1;NP_001954.2
Other Accession: NP_001954.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.